7b38aa8b-0cae-66b1-e053-2991aa0aeac8

SPL v1
SPL
SPL Set ID 7b38aa8b-0cae-66b1-e053-2991aa0aeac8
Route
oral
Published
Effective Date 2018-11-21
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
gestodene (0.075 mg) ethinyl estradiol (0.03 mg)
Inactive Ingredients
stearic acid starch, corn polyethylene glycol 6000

Identifiers & Packaging

Pill Appearance
Shape: round Color: white Size: 5 mm Score: 1
Marketing Status
unapproved drug other active Since 2018-11-22

Description

Gestodene, Ethinyl Estradiol


Medication Information

Warnings and Precautions

Warnings/Precautions:

Smokers over 35yrs of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended

Contraindications

Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Interactions

Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels

Adverse Reactions:

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

Active Ingredient

Gestodene, Ethinyl Estradiol

Indications and Usage

1 tab daily for 21 days; repeat.

Dosage and Administration

For oral use only

Description

Gestodene, Ethinyl Estradiol

Section 50565-1

Keep out of reach of children

Section 51727-6

Stearic acid, corn starch, polyethylene glycol 6000

Section 51945-4

Section 55105-1

Oral contraception


Structured Label Content

Warnings and Precautions (34071-1)

Warnings/Precautions:

Smokers over 35yrs of age: not recommended. Uncontrolled hypertension. Hypertriglyceridemia. Discontinue if jaundice, visual disturbances, migraine or other severe headaches occur. Do regular complete physical exams. May need barrier contraception with Sunday starts or postpartum use (see literature). Nursing mothers: not recommended

Contraindications

Thrombophlebitis or thromboembolic disorders. Cerebral vascular or coronary artery disease. Breast or other estrogen-dependent neoplasms. Undiagnosed abnormal genital bleeding. Cholestatic jaundice of pregnancy or jaundice with prior OC use. Hepatic adenoma or carcinoma. Pregnancy (Cat.X).

Interactions

Antagonized by hepatic enzyme inducing drugs (eg, rifampin, griseofulvin, St. John's wort), possibly others. May affect measurement of sex hormone-binding globulin levels

Adverse Reactions:

Hypertension, nausea, vomiting, breakthrough bleeding, amenorrhea, transient delay of ovulation after discontinuation, edema, chloasma, mastodynia, headache, intolerance to contact lenses. Increased risk of gallbladder disease, thromboembolic disorders.

Active Ingredient (55106-9)

Gestodene, Ethinyl Estradiol

Indications and Usage (34067-9)

1 tab daily for 21 days; repeat.

Dosage and Administration (34068-7)

For oral use only

Section 50565-1 (50565-1)

Keep out of reach of children

Section 51727-6 (51727-6)

Stearic acid, corn starch, polyethylene glycol 6000

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

Oral contraception


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)